Anlotinib Powder: A Breakthrough in Targeted Cancer Therapy
Explore the potent anti-cancer capabilities of Anlotinib powder, a key player in modern oncology treatments.
Get a Quote & SampleProduct Core Value
Anlotinib Powder
Anlotinib powder is a highly effective pharmaceutical raw material renowned for its role as a multi-target tyrosine kinase inhibitor. Its primary function is to disrupt key signaling pathways essential for tumor growth, proliferation, and angiogenesis, making it a crucial component in advanced cancer therapies.
- Discover the potential of Anlotinib powder for cancer treatment, a vital resource for pharmaceutical research and development.
- Understand the critical mechanism of action of Anlotinib, focusing on its role as a VEGFR and FGFR inhibitor in blocking tumor angiogenesis.
- Learn about the approved applications of Anlotinib powder in treating non-small cell lung cancer and soft tissue sarcoma, showcasing its therapeutic efficacy.
- Source high-purity Anlotinib powder for your research needs, ensuring reliable results in preclinical and clinical studies.
Key Advantages
Targeted Cancer Therapy
Leverage the precise targeting of Anlotinib to inhibit multiple receptor tyrosine kinases (RTKs), offering a more effective approach to cancer treatment compared to traditional therapies.
Inhibition of Angiogenesis
Anlotinib powder effectively curbs tumor growth by preventing the formation of new blood vessels, a critical process known as angiogenesis, which is vital for tumor survival.
Broad Spectrum Efficacy
Its proven efficacy in treating non-small cell lung cancer and soft-tissue sarcoma, along with ongoing research into other cancers, highlights the broad therapeutic potential of Anlotinib powder.
Key Applications
Oncology Research
Anlotinib powder serves as a critical reagent in oncology research, aiding in the study of targeted therapies and drug resistance mechanisms.
Pharmaceutical Manufacturing
As a vital Active Pharmaceutical Ingredient (API), Anlotinib powder is integral to the production of advanced anti-cancer medications.
Non-Small Cell Lung Cancer (NSCLC) Treatment
Anlotinib is an approved treatment option for patients with advanced or metastatic NSCLC, offering a new avenue for patient care.
Soft Tissue Sarcoma Therapy
Its application extends to treating advanced soft-tissue sarcoma, demonstrating Anlotinib's versatility in tackling different cancer types.